HVP
CVS icon

Hudson Value Partners’s CVS Health CVS Stock Holding History

Hudson Value Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,552
Closed -$3.04M – 98
2023
Q4 		$3.04M Sell
38,552
-1,551
-4% -$110K 1.42% 27
2023
Q3 		$2.8M Buy
40,103
+2,650
+7% +$188K 1.47% 24
2023
Q2 		$2.59M Sell
37,453
-2,654
-7% -$189K 1.32% 25
2023
Q1 		$2.98M Buy
40,107
+264
+0.7% +$22.1K 1.7% 20
2022
Q4 		$3.71M Sell
39,843
-100
-0.3% -$9.65K 2.28% 12
2022
Q3 		$3.81M Buy
39,943
+62
+0.2% +$6.14K 2.56% 7
2022
Q2 		$3.69M Buy
39,881
+10,622
+36% +$1.04M 2.34% 9
2022
Q1 		$2.96M Buy
29,259
+248
+0.9% +$26.1K 1.52% 24
2021
Q4 		$2.99M Buy
29,011
+233
+0.8% +$21.5K 1.45% 25
2021
Q3 		$2.44M Buy
28,778
+411
+1% +$34.4K 1.34% 26
2021
Q2 		$2.37M Buy
28,367
+205
+0.7% +$16.8K 1.31% 26
2021
Q1 		$2.12M Buy
28,162
+1,330
+5% +$96.9K 1.28% 26
2020
Q4 		$1.82M Buy
+26,832
New +$1.75M 1.22% 25

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hudson Value Partners's CVS Position: Q1 2024 in Review

Hudson Value Partners sold out of CVS Health (CVS) in Q1 2024, closing a stake of 38,552 shares — an estimated $3.04M sold.

Hudson Value Partners first reported a position in CVS in Q4 2020 and held it in 13 quarters. The position peaked at $3.81M in Q3 2022. 2,182 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Hudson Value Partners reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Hudson Value Partners sold 38,552 CVS Health shares in Q1 2024, an estimated $3.04M.
  • Hudson Value Partners first reported a position in CVS Health in Q4 2020 and held it in 13 quarters.
  • Hudson Value Partners's CVS Health position peaked at $3.81M in Q3 2022.
  • 2,182 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Hudson Value Partners's 13F filing for Q1 2024, filed 8 May 2024.